1. Suh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, et al. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 2001;15(3):700-6. http://dx.doi.org/10.1096/fj.00-0176com [DOI:10.1096/fj.00-0176com] [PMID] []

2. Salmon AB, Richardson A, Pérez VI. Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging? Free Radic Biol Med 2010;48(5):642-55. http://dx.doi.org/10.1016/j.freeradbiomed.2009.12.015 [DOI:10.1016/j.freeradbiomed.2009.12.015] [PMID] []

3. Hajam YA, Rani R, Ganie SY, Sheikh TA, Javaid D, Qadri SS, et al. Oxidative stress in human pathology and aging: Molecular mechanisms and perspectives. Cells 2022;11(3):552. http://dx.doi.org/10.3390/cells11030552 [DOI:10.3390/cells11030552] [PMID] []

4. Afrundeh R, Mohammadi R. Comparison of the effect of 6 weeks aerobic training on the activity of catalase enzyme and malondialdehyde in heart tissue of healthy and streptozotocin-diabetic male wistar rats (intervention: experimental). Stud Med Sci 2019;30(5):337-46. [Google Scholar]

5. Ezlegini F, MSC Student of Biochemistry, Department of Biochemistry, Islamic Azad University Shahrod Branch, shahrod, Iran, Eftekhari A, Firoozray M, MSC Student of Biochemistry, Department of Biochemistry, Islamic Azad University Shahrod Branch, shahrod, Iran, Professor, Department of Biochemistry, Islamic Azad University Shahrod Branch, shahrod, Iran (Corresponding Author). Evaluation of glutathione peroxide activity and oxidative stress in type 2 diabetic patients and their relationship with serum glucose level and blood lipid parameters in a case-control study. Stud Med Sci 2022;33(4):234-43. http://dx.doi.org/10.52547/umj.33.4.234 [DOI:10.52547/umj.33.4.234]

6. Rio D, Stewart D, Pellegrini AJ. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metabol Cardiovas Dis 2005;15:316-28. [DOI:10.1016/j.numecd.2005.05.003] [PMID]

7. Eftekhari A, Ezlegini F, Firoozray M. Determination of serum level of selenoprotein p and oxidative stress in type 2 diabetes patients and their correlation with serum level of glucose and lipid parameters as a Case-Control study. Stud Med Sci 2021;32(8):597-606. [DOI:10.52547/umj.32.8.597]

8. Reddy VN, Kasahara E, Hiraoka M, Lin L-R, Ho Y-S. Effects of variation in superoxide dismutases (SOD) on oxidative stress and apoptosis in lens epithelium. Exp Eye Res 2004;79(6):859-68. http://dx.doi.org/10.1016/j.exer.2004.04.005 [DOI:10.1016/j.exer.2004.04.005] [PMID]

9. Sastre J, Pallardó FV, Viña J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 2003;35(1):1-8. http://dx.doi.org/10.1016/s0891-5849(03)00184-9 [DOI:10.1016/S0891-5849(03)00184-9] [PMID]

10. Althubiti M, Elzubier M, Alotaibi GS, Althubaiti MA, Alsadi HH, Alhazmi ZA, et al. Beta 2 microglobulin correlates with oxidative stress in elderly. Exp Gerontol 2021;150(111359):111359. http://dx.doi.org/10.1016/j.exger.2021.111359 [DOI:10.1016/j.exger.2021.111359] [PMID]

11. Kwak H-B. Effects of aging and exercise training on apoptosis in the heart. J Exerc Rehabil 2013;9(2):212-9. http://dx.doi.org/10.12965/jer.130002 [DOI:10.12965/jer.130002] [PMID] []

12. Pagan LU, Gomes MJ, Gatto M, Mota GAF, Okoshi K, Okoshi MP. The role of oxidative stress in the aging heart. Antioxidants 2022;11(2):336. http://dx.doi.org/10.3390/antiox11020336 [DOI:10.3390/antiox11020336] [PMID] []

13. Rahimi MM, Bagheri A, Bagheri Y, Fathi E, Bagheri S, Nia AV, et al. Renoprotective effects of prazosin on ischemia-reperfusion injury in rats. Hum Exp Toxicol 2021;40(8):1263-73. http://dx.doi.org/10.1177/0960327121993224 [DOI:10.1177/0960327121993224] [PMID]

14. Pan J-Y, Lu W-H, Wu C-J, Tseng C-J, Chen H-H. Prazosin improves neurogenic acute heart failure through downregulation of fibroblast growth factor 23 in rat hearts. Chin J Physiol 2022;65(4):179-86. http://dx.doi.org/10.4103/cjp.cjp_9_22 [DOI:10.4103/cjp.cjp_9_22] [PMID]

15. Malekinejad Z, Aghajani S, Jeddi M, Qahremani R, Shahbazi S, Bagheri Y, et al. Prazosin treatment protects brain and heart by diminishing oxidative stress and apoptotic pathways after renal ischemia reperfusion. Drug Res 2022;72(6):336-42. http://dx.doi.org/10.1055/a-1806-1453 [DOI:10.1055/a-1806-1453] [PMID]

16. Liu S, Li W. Prazosin blocks apoptosis of endothelial progenitor cells through downregulating the Akt/NF-κB signaling pathway in a rat cerebral infarction model. Exp Ther Med 2020;20(3):2577-84. http://dx.doi.org/10.3892/etm.2020.9009 [DOI:10.3892/etm.2020.9009]

17. Lee J-Y, Song Y-W, Shim M-J, Kim S-W. Cure rate of DGEBA/MDA/GN/HQ system by differential scanning calorimetry analysis. Mater Chem Phys 1997;50(3):256-60. http://dx.doi.org/10.1016/s0254-0584(97)01946-9 [DOI:10.1016/S0254-0584(97)01946-9]

18. Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure: JACC review topic of the week. J Am Coll Cardiol 2019;74(6):804-13. http://dx.doi.org/10.1016/j.jacc.2019.06.053 [DOI:10.1016/j.jacc.2019.06.053] [PMID]

19. Ray PD, Huang B-W, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012;24(5):981-90. http://dx.doi.org/10.1016/j.cellsig.2012.01.008 [DOI:10.1016/j.cellsig.2012.01.008] [PMID] []

20. Joseph A-M, Adhihetty PJ, Leeuwenburgh C. Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle: Effect of exercise-induced adaptations in muscle mitochondria with ageing. J Physiol 2016;594(18):5105-23. http://dx.doi.org/10.1113/jp270659 [DOI:10.1113/JP270659] [PMID] []

21. Gao X-H, Qanungo S, Pai HV, Starke DW, Steller KM, Fujioka H, et al. Aging-dependent changes in rat heart mitochondrial glutaredoxins--Implications for redox regulation. Redox Biol 2013;1(1):586-98. http://dx.doi.org/10.1016/j.redox.2013.10.010 [DOI:10.1016/j.redox.2013.10.010] [PMID] []

22. Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging 2018;13:757-72. http://dx.doi.org/10.2147/cia.s158513 [DOI:10.2147/CIA.S158513] [PMID] []

23. Chen MS, Lee RT, Garbern JC. Senescence mechanisms and targets in the heart. Cardiovasc Res 2022;118(5):1173-87. http://dx.doi.org/10.1093/cvr/cvab161 [DOI:10.1093/cvr/cvab161] [PMID] []

24. Wongsurawat T, Woo CC, Giannakakis A, Lin XY, Cheow ESH, Lee CN, et al. Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction. Atherosclerosis 2018;271:237-44. http://dx.doi.org/10.1016/j.atherosclerosis.2018.01.024 [DOI:10.1016/j.atherosclerosis.2018.01.024] [PMID]

25. Papaconstantinou J. The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease. Cells 2019;8(11):1383. http://dx.doi.org/10.3390/cells8111383 [DOI:10.3390/cells8111383] [PMID] []

26. Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, et al. Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies. Eur J Prev Cardiol 2020;27(5):494-510. http://dx.doi.org/10.1177/2047487319870344 [DOI:10.1177/2047487319870344] [PMID]

27. Dasari TW, Chakraborty P, Mukli P, Akhtar K, Yabluchanskiy A, Cunningham MW, et al. Noninvasive low-level tragus stimulation attenuates inflammation and oxidative stress in acute heart failure. Clin Auton Res 2023; http://dx.doi.org/10.1007/s10286-023-00997-z [DOI:10.1007/s10286-023-00997-z] [PMID]

28. Choleva M, Argyrou C, Detopoulou M, Donta M-E, Gerogianni A, Moustou E, et al. Effect of moderate wine consumption on oxidative stress markers in coronary heart disease patients. Nutrients 2022;14(7):1377. http://dx.doi.org/10.3390/nu14071377 [DOI:10.3390/nu14071377] [PMID] []

29. Yoshitomi R, Kobayashi S, Yano Y, Nakashima Y, Fujii S, Nanno T, et al. Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis. Heart 2022;108(6):429-37. http://dx.doi.org/10.1136/heartjnl-2021-320244 [DOI:10.1136/heartjnl-2021-320244] [PMID] []

30. Chi R-F, Li L, Wang A-L, Yang H, Xi J, Zhu Z-F, et al. Enhanced oxidative stress mediates pathological autophagy and necroptosis in cardiac myocytes in pressure overload induced heart failure in rats. Clin Exp Pharmacol Physiol 2022;49(1):60-9. http://dx.doi.org/10.1111/1440-1681.13583 [DOI:10.1111/1440-1681.13583] [PMID]

31. Kumar A, Supowit S, Potts JD, DiPette DJ. Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress. Physiol Rep 2019;7(21):e14269. http://dx.doi.org/10.14814/phy2.14269 [DOI:10.14814/phy2.14269]

32. Chiş IC, Baltaru D, Dumitrovici A, Coseriu A, Radu BC, Moldovan R, et al. Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat's heart. Physiol Int 2018;105(3):233-46. http://dx.doi.org/10.1556/2060.105.2018.3.23 [DOI:10.1556/2060.105.2018.3.23] [PMID]

33. Xie D-M, Zhong Q, Xu X, Li Y, Chen S, Li M, et al. Alpha lipoic acid-loaded electrospun fibrous patch films protect heart in acute myocardial infarction mice by inhibiting oxidative stress. Int J Pharm 2023;632(122581):122581. http://dx.doi.org/10.1016/j.ijpharm.2023.122581 [DOI:10.1016/j.ijpharm.2023.122581] [PMID]

34. Prasad K, McNair ED, Caspar-Bell G, Mabood Qureshi A. Vitamin E does not regress hypercholesterolemia-induced oxidative stress in heart. Mol Cell Biochem 2014;391(1-2):211-6. http://dx.doi.org/10.1007/s11010-014-2004-8 [DOI:10.1007/s11010-014-2004-8] [PMID]

35. Neha K, Haider MR, Pathak A, Yar MS. Medicinal prospects of antioxidants: A review. Eur J Med Chem 2019;178:687-704. http://dx.doi.org/10.1016/j.ejmech.2019.06.010 [DOI:10.1016/j.ejmech.2019.06.010] [PMID]

36. Johnson K, Oparil S, Davis BR, Tereshchenko LG. Prevention of heart failure in hypertension-disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: The ALLHAT study. J Am Heart Assoc 2019;8(8):e011961. http://dx.doi.org/10.1161/JAHA.119.011961 [DOI:10.1161/JAHA.119.011961] [PMID] []

37. Zhao L-S, Xu C-Y. Effect of prazosin on diabetic nephropathy patients with positive α1-adrenergic receptor autoantibodies and refractory hypertension. Exp Ther Med 2015;9(1):177-82. http://dx.doi.org/10.3892/etm.2014.2036 [DOI:10.3892/etm.2014.2036] [PMID] []

38. Wang L, Xue Y, Ma H, Shi H, Wang L, Cui X. Prazosin protects myocardial cells against anoxia-reoxygenation injury via the extracellular signal regulated kinase signaling pathway. Mol Med Rep 2017; http://dx.doi.org/10.3892/mmr.2017.8175 [DOI:10.3892/mmr.2017.8175]